GKB Ophthalmics Ltd Board Meeting Set to Approve Q1 Unaudited Financial Results; Trading Window Reopening Scheduled
GKB Ophthalmics Ltd has scheduled a meeting of its Board of Directors to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.The board meeting is set for Wednesday, August 12, 2026. The primary agenda item for the meeting is the review and approval of the company's financial results as of June 30, 2026.
Separately, the company provided an update regarding its trading window status. Designated persons had closed the trading window for dealing with equity shares starting from July 01, 2026. The trading window is set to reopen after a period of 48 hours following the submission of financial results to the Stock Exchange.
Stock Price Movement
GKB Ophthalmics Ltd settled on Friday at ₹57.49, ticking up 4.34% in after-hours trading. The shares experienced movement throughout the day, staying within an intraday range bounded by a low of ₹55.15 and a high of ₹57.49.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.